F913-0251 Screening compound: 5-(phenoxymethyl)-N-(4-{[3-(piperidin-1-yl)propyl]carbamoyl}phenyl)-1,3,4-thiadiazole-2-carboxamide

F913-0251 Screening compound: 5-(phenoxymethyl)-N-(4-{[3-(piperidin-1-yl)propyl]carbamoyl}phenyl)-1,3,4-thiadiazole-2-carboxamide
F913-0251 Screening compound: 5-(phenoxymethyl)-N-(4-{[3-(piperidin-1-yl)propyl]carbamoyl}phenyl)-1,3,4-thiadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F913-0251
5-(phenoxymethyl)-N-(4-{[3-(piperidin-1-yl)propyl]carbamoyl}phenyl)-1,3,4-thiadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F913-0251

Molecular Formula

C25H29N5O3S (C25 H29 N5 O3 S)

Compound Name

5-(phenoxymethyl)-N-(4-{[3-(piperidin-1-yl)propyl]carbamoyl}phenyl)-1,3,4-thiadiazole-2-carboxamide

IUPAC name

5-(phenoxymethyl)-N-(4-{[3-(piperidin-1-yl)propyl]carbamoyl}phenyl)-134-thiadiazole-2-carboxamide

SMILES

O=C(c1nnc(COc2ccccc2)s1)Nc(cc1)ccc1C(NCCCN1CCCCC1)=O

InChI

InChI=1S/C25H29N5O3S/c31-23(26-14-7-17-30-15-5-2-6-16-30)19-10-12-20(13-11-19)27-24(32)25-29-28-22(34-25)18-33-21-8-3-1-4-9-21/h1,3-4,8-13H,2,5-7,14-18H2,(H,26,31)(H,27,32)

InChI Key

ISKFBKYJJCYUNR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14970777

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.050

Distribution Coefficient, logD

0.454

Water Solubility, LogSw

-3.41

Polar Surface Area

82.794

Acid Dissociation Constant (pKa)

9.21

Base Dissociation Constant (pKb)

10.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

F913-0251 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with F913-0251 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F913-0251?
Check Price and Availability of F913-0251, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F913-0251 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F913-0251
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F913-0251
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F913-0251 available by request